FOLFOXIRI + Bevacizumab + Atezolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFOXIRI + Bevacizumab + Atezolizumab, covering 2023-10-12 to 2023-10-12. Get the full timeline:
Most recent: Clinical Trial Update: FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients [Phase 2]